01

Evonik

Germany

CPhI India

Booth #6.M14

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® L 12,5

Application : Solubilizers

Excipient Details : EUDRAGIT® L 12,5 (organic solution), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets and capsules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Category : Solubilizers

Brand : EUDRAGIT® L 12,5

Applications : EUDRAGIT® L 12,5 (organic solution), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets and capsules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

02

Evonik

Germany

CPhI India

Booth #6.M14

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® L 30 D-55

Application : Coating Systems & Additives, Film Formers & Plasticizers

Excipient Details : EUDRAGIT® L 30 D-55 (aqueous dispersion) is a delayed release polymer used as coating and film former in tablets, capsules, granules etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form : Capsule, Tablet

Category : Coating Systems & Additives, Film Formers & Plasticizers

Brand : EUDRAGIT® L 30 D-55

Applications : EUDRAGIT® L 30 D-55 (aqueous dispersion) is a delayed release polymer used as coating and film former in tablets, capsules, granules etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

03

Evonik

Germany

CPhI India

Booth #6.M14

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® L 100

Application : Controlled & Modified Release, Solubilizers

Excipient Details : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Category : Controlled & Modified Release, Solubilizers

Brand : EUDRAGIT® L 100

Applications : EUDRAGIT® L 100 (powder), a delayed release polymer is used to increase solubility of poorly soluble products such as tablets, capsules, ODTs, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

04

Evonik

Germany

CPhI India

Booth #6.M14

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Brand Name : EUDRAGIT® L 100-55

Application : Coating Systems & Additives, Controlled & Modified Release, Solubilizers

Excipient Details : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form : Capsule, Granule / Pellet, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid - Ethyl Acrylate Copolymer

Dosage Form : Capsule, Granule / Pellet, Tablet

Category : Coating Systems & Additives, Controlled & Modified Release, Solubilizers

Brand : EUDRAGIT® L 100-55

Applications : EUDRAGIT® L 100-55 (powder) is used in delayed release coatings to enhance solubility of poorly soluble drugs such as tablets, capsules & granules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

05

Evonik

Germany

CPhI India

Booth #6.M14

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® S 12,5

Application : Solubilizers

Excipient Details : EUDRAGIT® S 12,5 (Organic solution) a delayed release polymer, used to increase solubility of poorly soluble drugs such as tablets and capsules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Category : Solubilizers

Brand : EUDRAGIT® S 12,5

Applications : EUDRAGIT® S 12,5 (Organic solution) a delayed release polymer, used to increase solubility of poorly soluble drugs such as tablets and capsules.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

06

Evonik

Germany

CPhI India

Booth #6.M14

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® FL 30 D-55

Application : Coating Systems & Additives

Excipient Details : EUDRAGIT® FL 30 D-55 (aqueous dispersion of a combination polymers) is used OSDs coating without addition of plasticizer, utilizing AEMP technology.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Ethyl Acrylate and Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ethyl Acrylate and Methyl Methacrylate Copolymer

Dosage Form : Capsule, Tablet

Category : Coating Systems & Additives

Brand : EUDRAGIT® FL 30 D-55

Applications : EUDRAGIT® FL 30 D-55 (aqueous dispersion of a combination polymers) is used OSDs coating without addition of plasticizer, utilizing AEMP technology.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

07

Evonik

Germany

CPhI India

Booth #6.M14

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® RL 100

Application : Controlled & Modified Release, Solubilizers

Excipient Details : EUDRAGIT® RL 100 (granules) is an excipient used as a solubilizer in combination with Eudragit® RS for creating sustained release drugs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Ammonia Methacrylate Copolymer Type A

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ammonia Methacrylate Copolymer Type A

Dosage Form : Capsule, Tablet

Category : Controlled & Modified Release, Solubilizers

Brand : EUDRAGIT® RL 100

Applications : EUDRAGIT® RL 100 (granules) is an excipient used as a solubilizer in combination with Eudragit® RS for creating sustained release drugs.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

08

Evonik

Germany

CPhI India

Booth #6.M14

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® RS 100

Application : Controlled & Modified Release, Solubilizers

Excipient Details : EUDRAGIT® RS, a functional sustained release polymer, used in combination with EUDRAGIT® RL for customized release profiles in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Ammonio Methacrylate Copolymer Type B

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ammonio Methacrylate Copolymer Type B

Dosage Form : Capsule, Tablet

Category : Controlled & Modified Release, Solubilizers

Brand : EUDRAGIT® RS 100

Applications : EUDRAGIT® RS, a functional sustained release polymer, used in combination with EUDRAGIT® RL for customized release profiles in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

09

Evonik

Germany

CPhI India

Booth #6.M14

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Granule / Pellet, Tablet

Grade : Oral

Brand Name : EUDRAGIT® RL 30 D

Application : Controlled & Modified Release

Excipient Details : Eudragit RL 30 D(aqueous dispersion) is a sustained release polymer for customized release profiles, used in combination with EUDRAGIT® RS.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Ethyl Acrylate and Methyl Methacrylate Copolymer

Dosage Form : Granule / Pellet, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Ethyl Acrylate and Methyl Methacrylate Copolymer

Dosage Form : Granule / Pellet, Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® RL 30 D

Applications : Eudragit RL 30 D(aqueous dispersion) is a sustained release polymer for customized release profiles, used in combination with EUDRAGIT® RS.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

10

Evonik

Germany

CPhI India

Booth #6.M14

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Dosage Form : Capsule, Tablet

Grade : Oral

Brand Name : EUDRAGIT® S 100

Application : Controlled & Modified Release

Excipient Details : EUDRAGIT® S 100, a delayed release polymer can be combined with other polymers for precise targeting and rapid drug release in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer 1:2

Dosage Form : Capsule, Tablet

Grade : Oral

Evonik's CDMO solutions for APIs and HPAPIs: It specializes where the client needs it most!

Ingredient(s) : Methacrylic Acid Methyl Methacrylate Copolymer 1:2

Dosage Form : Capsule, Tablet

Category : Controlled & Modified Release

Brand : EUDRAGIT® S 100

Applications : EUDRAGIT® S 100, a delayed release polymer can be combined with other polymers for precise targeting and rapid drug release in tablets, capsules, etc.

Pharmacopoeia Ref : NA

Technical Specs : NA

Grade : Oral

Looking for Diltiazem Hydrochloride? Find Diltiazem Hydrochloride based excipient solutions to address drug delivery challenges on PharmaCompass.

Diltiazem Hydrochloride

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

55 API Suppliers

21 USDMF

8 CEP/COS

5 JDMF

6 EU WC

6 KDMF

16 NDC API

25 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

8 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

391 FDF Dossiers

234 FDA Orange Book

40 Europe

84 Canada

7 South Africa

26 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 120MG

TABLET;ORAL - 30MG

TABLET;ORAL - 60MG

TABLET;ORAL - 90MG

CAPSULE, EXTENDED RELEASE;ORAL - 120MG

CAPSULE, EXTENDED RELEASE;ORAL - 180MG

CAPSULE, EXTENDED RELEASE;ORAL - 240MG

CAPSULE, EXTENDED RELEASE;ORAL - 300MG

CAPSULE, EXTENDED RELEASE;ORAL - 360MG

CAPSULE, EXTENDED RELEASE;ORAL - 120MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 180MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 120MG

CAPSULE, EXTENDED RELEASE;ORAL - 180MG

CAPSULE, EXTENDED RELEASE;ORAL - 240MG

CAPSULE, EXTENDED RELEASE;ORAL - 300MG

CAPSULE, EXTENDED RELEASE;ORAL - 360MG

CAPSULE, EXTENDED RELEASE;ORAL - 420MG

TABLET, EXTENDED RELEASE;ORAL - 120MG

TABLET, EXTENDED RELEASE;ORAL - 180MG

TABLET, EXTENDED RELEASE;ORAL - 240MG

TABLET, EXTENDED RELEASE;ORAL - 300MG

TABLET, EXTENDED RELEASE;ORAL - 360MG

TABLET, EXTENDED RELEASE;ORAL - 420MG

RELATED EXCIPIENT COMPANIES

14 Evonik

3 Rochem International Inc

20 SPI Pharma

13 DKSH

6 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

2 Pfanstiehl

7 Kirsch Pharma

4 ACG Worldwide

10 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

32 BASF

1 CD Formulation

22 Corel Pharma Chem

5 DFE Pharma

1 Esteem Industries

2 Finar

11 Gangwal Chemicals

12 Ideal Cures

4 Ingredion Pharma Solutions

20 Kerry

3 Keval Exports

5 Kima Chemical

CAPSULE, EXTENDED RELEASE;ORAL - 120MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 180MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 240MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons